If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvoke Plc Regulatory News (EVOK)

Share Price Information for Evoke Plc (EVOK)

Share Price is delayed by 15 minutes
Get Live Data
47.00    0.55 (1.18%)
Bid:
46.20
Ask:
47.00
Spread: 0.80 (1.732%)
Market Cap: £211.56m
EVOK Live PriceLast checked at - London Stock Exchange

Intraday Evoke Plc Share Chart

Strategic Review

10 Dec 2025 10:53

RNS Number : 0271L
Evoke PLC
10 December 2025
 

 

10 December 2025

 

For immediate release

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

evoke Plc

("evoke", the "Company", or the "Group")

 

Strategic Review

Further to the Company's announcement on 26 November 2026, and following recent media speculation, the board of directors of the Company confirms it has decided to undertake a review of the Company's strategic options, which will include the consideration of a range of potential alternatives to maximise shareholder value, including, but not limited to a potential sale of the Group, or some of the Company's assets and/or business units.

The board has appointed Morgan Stanley & Co. International plc and Rothschild & Co as its joint financial advisers in connection with the strategic review.

Shareholders are advised that there is no certainty that any transaction will materialise, nor as to the terms of any transaction.

Further announcements will be made when and if appropriate.

 

Enquiries and further information:

evoke Plc

+44(0) 800 029 3050

Per Widerström, CEO

Sean Wilkins, CFO

Elizabeth Bisby, Company Secretary

 

Investor Relations

James Finney, Director of IR

 

Morgan Stanley & Co. International plc(joint financial adviser)

 

ir@evokeplc.com

 

 

+44(0)20 7425 8000

Ben Grindley

Paolo Della Rovere 

N.M. Rothschild & Sons Limited ("Rothschild & Co") (joint financial adviser)

+44(0)20 7280 5000

Daniel Ross

Edward Duckett

 

Hudson Sandler

(public relations)

Alex Brennan

Hattie Dreyfus

+44(0)20 7796 4133

Evoke@hudsonsandler.com

 

About evoke Plc:

evoke plc (and together with its subsidiaries, "evoke" or the "Group") is one of the world's leading betting and gaming companies. The Group owns and operates internationally renowned brands including William Hill, 888, and Mr Green. Incorporated in Gibraltar, and headquartered and listed in London, the Group operates from offices around the world.

The Group's vision is to make life more interesting and its mission is to delight players with world-class betting and gaming experiences.

Find out more at: https://www.evokeplc.com

Further information:

Morgan Stanley & Co. International plc ("Morgan Stanley"), which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the PRA and the Financial Conduct Authority ("FCA") in the United Kingdom, is acting exclusively for evoke and for no one else in connection with the strategic review and neither Morgan Stanley nor any of its affiliates, nor their respective directors, officers, employees or agents will be responsible to anyone other than evoke for providing the protections afforded to its clients or for providing advice in relation to the contents of this announcement or any other matters referred to in this announcement.

The City Code on Takeovers and Mergers

The City Code on Takeovers and Mergers (the "Code") does not apply to the Company as it is registered in Gibraltar. As a result, a takeover offer for the Company will not be regulated by the UK Panel on Takeovers and Mergers (the "Panel"). The Company's articles of association contain certain takeover-related provisions, although these do not provide the full protections afforded by the Code and the enforcement of such provisions is the responsibility of the Company, not the Panel. Accordingly, shareholders of the Company are reminded that the Panel does not have responsibility, in relation to the Company, for ensuring compliance with the Code and is not able to answer shareholders' questions in that regard.

In particular, public disclosures consistent with the provisions of Rule 8 of the Code (as if it applied to the Company) should not be emailed to the Panel, but as described below, released directly through a Regulatory Information Service.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBBLFFELLEFBL
Date   Source Headline
30th Apr 20255:53 pmRNSNotification of Transactions by PDMR
25th Apr 20258:00 amRNSNotice of AGM
25th Apr 20257:00 amRNSQ1 2025 trading update
22nd Apr 20257:43 amRNSNotice of Q1 2025 trading update
22nd Apr 20257:00 amRNSHolding(s) in Company
14th Apr 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Apr 20258:16 amRNSHolding(s) in Company
2nd Apr 20258:15 amRNSHolding(s) in Company
2nd Apr 20257:00 amRNSPublication of Annual Report
1st Apr 20259:08 amRNSNotification of Transactions by PDMR
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20259:28 amRNSAwards Granted under the Long Term Incentive Plan
26th Mar 20257:00 amRNSFY2024 Results
25th Mar 20259:13 amRNSHolding(s) in Company
3rd Mar 20257:00 amRNSTotal Voting Rights
17th Feb 20257:00 amRNSNotice of Results
3rd Feb 20258:15 amRNSTotal Voting Rights
29th Jan 20257:00 amRNSNotification of Transactions by PDMR
17th Jan 20257:05 amRNSevoke Announcement Containing Company Information
17th Jan 20257:00 amRNS2024 Post-close Trading Update
13th Jan 20254:30 pmRNSNotice of Trading Update
10th Jan 20253:34 pmRNSHolding(s) in Company
2nd Jan 20257:00 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSTotal Voting Rights
11th Nov 202410:23 amRNSHolding(s) in Company
1st Nov 20249:23 amRNSHolding(s) in Company
1st Nov 20247:00 amRNSTotal Voting Rights
29th Oct 202411:41 amRNSHolding(s) in Company
23rd Oct 20247:00 amRNSBlock Listing Six Monthly Return
18th Oct 20247:05 amRNSevoke Announcement Containing Company Information
18th Oct 20247:00 amRNSQ3 2024 trading update
11th Oct 20249:30 amRNSNotice of Q3 2024 trading update
1st Oct 20247:00 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSAppointment of a Non-Executive Director
10th Sep 20248:43 amRNSDirector Declaration
2nd Sep 20247:00 amRNSTotal Voting Rights
23rd Aug 20247:00 amRNSAcquisition of Winner.ro
21st Aug 20248:52 amRNSNotification of Transactions by PDMR
19th Aug 20245:01 pmRNSNotification of Transactions by PDMR
16th Aug 20247:00 amRNSNotification of Transactions by PDMR
16th Aug 20247:00 amRNSNotification of Transactions by PDMR
15th Aug 20243:10 pmRNSNotification of Transactions by PDMR
15th Aug 20247:05 amRNSevoke Announcement Containing Company Information
15th Aug 20247:00 amRNSH1 2024 Interim Results
2nd Aug 20249:21 amRNSNotice of Interim Results
1st Aug 20247:00 amRNSTotal Voting Rights
18th Jul 20247:05 amRNSevoke Announcement Containing Company Information
18th Jul 20247:00 amRNSH1 2024 Trading Update
1st Jul 20249:40 amRNSWilliam Hill Limited - Annual Financial Report
1st Jul 20247:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.